Technology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET Study

Inclusion Criteria * AIM 1: Medical oncologists, radiation oncologists and urologists spanning Veterans Affairs (VA), academic, and community settings * AIM 2: Any English speaking man \>= 18 with PCA who has computer and web-access and meets any one of the following: * Metastatic disease * T3a or higher * Prostate specific antigen (PSA) \> 20 * Grade group 4 or higher * Intraductal or cribriform histology * Biochemical recurrence * Ashkenazi Jewish ancestry * Family history criteria (see below) \*\* Family history: If any one of the following levels are met, the person is eligible: * Level 1: \>= 1 close blood relative (first degree relative \[FDR\], second degree relative \[SDR\], third degree relative \[TDR\]) diagnosed with breast cancer =\< age 50 or the following cancers at any age: pancreatic, ovarian, or metastatic or intraductal/cribriform prostate cancer * Level 2: \>= 2 close blood relatives (FDR, SDR, TDR) on same side of the family with breast or prostate cancer at any age * Level 3: one brother, father, or \>= 2 family members (close blood relatives - FDR, SDR, TDR) on the same side of the family diagnosed with prostate cancer at \< 60 * Level 4: \>= 3 cancers on the same side of the family (especially if diagnosed =\< 50): bile duct, breast, colorectal, endometrial, gastric, kidney, melanoma, ovarian, pancreatic, prostate (grade groups 2-5 if known), small bowel, or urothelial Exclusion Criteria * Age \< 18 years * Mental or…